相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
Francesco Panza et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease
Kaj Blennow et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab
Christopher Carlson et al.
ALZHEIMERS & DEMENTIA (2011)
Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS-708163 in patients with mild-to-moderate AD
Reisa Sperling et al.
Alzheimers & Dementia (2011)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
Ronald S. Black et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid beta After a Single Administration of an Amyloid beta Monoclonal Antibody in Subjects With Alzheimer Disease
Eric R. Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2010)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Dose-finding in phase I clinical trials based on toxicity probability intervals
Yuan Ji et al.
CLINICAL TRIALS (2007)
The F(ab′)2 fragment of an Aβ-specific monoclonal antibody reduces Aβ deposits in the brain
Y Tamura et al.
NEUROBIOLOGY OF DISEASE (2005)
分享论文
